Provided herein are methods for treating an individual for a disease (e.g., an autoimmune disease or a cancer) using an active agent which affects metabolism of α-ketoglutarate (α-KG) and/or 2-hydroxyglutarate (2-HG) in differentiating T cells. In some embodiments, a Got1 inhibitor is used to generate a population of T cells enriched in peripheral regulatory T (iTreg) cells, which population enriched in iTreg cells may find use in treating an autoimmune disease. In some embodiments, a TCA cycle-associated metabolite, or a derivative thereof, is used to generate a population of T cells in enriched in IL-17- and IL-17F-producing CD4 T (TH17) cells, which population enriched in TH17 cells may find use in treating a cancer.
本文提供了一种治疗个体患病(例如自身免疫疾病或癌症)的方法,使用影响α-酮
戊二酸(α-KG)和/或2-羟基
戊二酸(2-
HG)在分化T细胞中代谢的活性剂。在某些实施例中,使用Got1
抑制剂生成富集于外周调节性T细胞(iTreg)细胞的T细胞群,这种富集于iTreg细胞的群体可用于治疗自身免疫疾病。在某些实施例中,使用
TCA循环相关代谢物或其衍
生物生成富含IL-17和IL-17F产生的C
D4 T(TH17)细胞的T细胞群,这种富含TH17细胞的群体可用于治疗癌症。